Phage-inspired strategies to combat antibacterial resistance.

IF 6 2区 生物学 Q1 MICROBIOLOGY
Critical Reviews in Microbiology Pub Date : 2024-03-01 Epub Date: 2023-02-21 DOI:10.1080/1040841X.2023.2181056
Mianzhi Wang, Junxuan Zhang, Jingyi Wei, Lei Jiang, Li Jiang, Yongxue Sun, Zhenling Zeng, Zhiqiang Wang
{"title":"Phage-inspired strategies to combat antibacterial resistance.","authors":"Mianzhi Wang, Junxuan Zhang, Jingyi Wei, Lei Jiang, Li Jiang, Yongxue Sun, Zhenling Zeng, Zhiqiang Wang","doi":"10.1080/1040841X.2023.2181056","DOIUrl":null,"url":null,"abstract":"<p><p>Antimicrobial resistance (AMR) in clinically priority pathogensis now a major threat to public health worldwide. Phages are bacterial parasites that efficiently infect or kill specific strains and represent the most abundant biological entities on earth, showing great attraction as potential antibacterial therapeutics in combating AMR. This review provides a summary of phage-inspired strategies to combat AMR. We firstly cover the phage diversity, and then explain the biological principles of phage therapy that support the use of phages in the post-antimicrobial era. Furthermore, we state the versatility methods of phage therapy both from direct access as well as collateral access. Among the direct access approaches, we discuss the use of phage cocktail therapy, phage-encoded endolysins and the bioengineering for function improvement of used phages or endolysins. On the other hand, we introduce the collateral access, including the phages antimicrobial immunity combined therapy and phage-based novel antibacterial mimic molecules. Nowadays, more and more talented and enthusiastic scientist, doctors, pharmacists, media, authorities, and industry are promoting the progress of phage therapy, and proposed more phages-inspired strategy to make them more tractable to combat AMR and benefit more people, more animal and diverse environment in \"one health\" framework.</p>","PeriodicalId":10736,"journal":{"name":"Critical Reviews in Microbiology","volume":"1 1","pages":"196-211"},"PeriodicalIF":6.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical Reviews in Microbiology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1080/1040841X.2023.2181056","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/2/21 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Antimicrobial resistance (AMR) in clinically priority pathogensis now a major threat to public health worldwide. Phages are bacterial parasites that efficiently infect or kill specific strains and represent the most abundant biological entities on earth, showing great attraction as potential antibacterial therapeutics in combating AMR. This review provides a summary of phage-inspired strategies to combat AMR. We firstly cover the phage diversity, and then explain the biological principles of phage therapy that support the use of phages in the post-antimicrobial era. Furthermore, we state the versatility methods of phage therapy both from direct access as well as collateral access. Among the direct access approaches, we discuss the use of phage cocktail therapy, phage-encoded endolysins and the bioengineering for function improvement of used phages or endolysins. On the other hand, we introduce the collateral access, including the phages antimicrobial immunity combined therapy and phage-based novel antibacterial mimic molecules. Nowadays, more and more talented and enthusiastic scientist, doctors, pharmacists, media, authorities, and industry are promoting the progress of phage therapy, and proposed more phages-inspired strategy to make them more tractable to combat AMR and benefit more people, more animal and diverse environment in "one health" framework.

噬菌体激发的对抗抗菌耐药性的策略
目前,临床重点病原体的抗菌药耐药性(AMR)已成为全球公共卫生的一大威胁。噬菌体是细菌寄生虫,能有效感染或杀死特定菌株,是地球上最丰富的生物实体,作为潜在的抗菌疗法,在抗击 AMR 方面显示出巨大的吸引力。本综述概述了噬菌体启发的抗 AMR 战略。我们首先介绍了噬菌体的多样性,然后解释了噬菌体疗法的生物学原理,这些原理支持在后抗微生物时代使用噬菌体。此外,我们还阐述了噬菌体疗法的多功能方法,包括直接获取和附带获取两种方法。在直接获取方法中,我们讨论了噬菌体鸡尾酒疗法、噬菌体编码内溶素以及生物工程改善所用噬菌体或内溶素功能的方法。另一方面,我们还介绍了附带途径,包括噬菌体抗菌免疫联合疗法和基于噬菌体的新型抗菌模拟分子。如今,越来越多才华横溢、热情洋溢的科学家、医生、药剂师、媒体、权威机构和产业界都在推动噬菌体疗法的进步,并提出了更多噬菌体启发策略,使其更具可操作性,以对抗 AMR,在 "同一健康 "框架下造福更多人、更多动物和多样化环境。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Critical Reviews in Microbiology
Critical Reviews in Microbiology 生物-微生物学
CiteScore
14.70
自引率
0.00%
发文量
99
期刊介绍: Critical Reviews in Microbiology is an international, peer-reviewed journal that publishes comprehensive reviews covering all areas of microbiology relevant to humans and animals, including medical and veterinary microbiology, public health and environmental microbiology. These may include subjects related to microbial molecular biology, immunopathogenicity, physiology, biochemistry, structure, and epidemiology. Of particular interest are reviews covering clinical aspects of bacterial, virological, fungal and parasitic diseases. All reviews must be analytical, comprehensive, and balanced in nature. Editors welcome uninvited submissions, as well as suggested topics for reviews accompanied by an abstract.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信